ROBERT NELSEN Insider Trading $SYRS Syros Pharmaceuticals, Inc.
Get free email notifications about insider trading for ROBERT NELSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Sage Therapeutics, Inc. ($SAGE) and in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Vir Biotechnology, Inc. ($VIR) and Director in Beam Therapeutics Inc. ($BEAM) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX) and Director in Lyell Immunopharma, Inc. ($LYEL) and Director in Sana Biotechnology, Inc. ($SANA).
ROBERT NELSEN in Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 479,999 shares
Current Value: $5,241,589
Latest Transaction: Jun 12 2017
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT NELSEN in Syros Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2017 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
| Sep 19 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,589,269 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | P | 12.50 | 400,000 | 5,000,000 | 4,637,137 | 4.2 M to 4.6 M (+9.44 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 423,805 | 0 | 4,237,137 | 3.8 M to 4.2 M (+11.11 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,000,000 | 0 | 3,813,332 | 1.8 M to 3.8 M (+110.29 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,333,333 | 0 | 1,813,332 | 480 K to 1.8 M (+277.78 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 266,666 | 0 | 479,999 | 213.3 K to 480 K (+125.00 %) |
Page: 1